Variant report
Variant | nsv965510 |
---|---|
Chromosome Location | chr5:58802295-58809224 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:10)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:10 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:58801703..58803307-chr5:58968055..58970489,2 | MCF-7 | breast: | |
2 | chr5:58802090..58802764-chr5:58956093..58957045,3 | MCF-7 | breast: | |
3 | chr5:58803367..58805536-chr5:58956722..58959458,2 | MCF-7 | breast: | |
4 | chr5:58803075..58803840-chr5:58956390..58957074,2 | MCF-7 | breast: | |
5 | chr5:58802160..58802725-chr5:58865559..58866459,3 | MCF-7 | breast: | |
6 | chr5:58801963..58802644-chr5:58962690..58963296,2 | MCF-7 | breast: | |
7 | chr5:58801995..58802802-chr5:58968998..58969985,2 | MCF-7 | breast: | |
8 | chr5:58806024..58808912-chr5:58817531..58819530,2 | MCF-7 | breast: | |
9 | chr5:58801872..58802902-chr5:58956210..58957251,7 | MCF-7 | breast: | |
10 | chr5:58801867..58802786-chr5:58968976..58969858,3 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs574803461 | chr5:58802312-58802313 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs79049894 | chr5:58802386-58802387 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs557129075 | chr5:58802411-58802412 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs562168308 | chr5:58802415-58802416 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs188743859 | chr5:58802462-58802463 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs180771572 | chr5:58802517-58802518 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs565080542 | chr5:58802533-58802534 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs141063311 | chr5:58802542-58802543 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs547615236 | chr5:58802616-58802617 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs185978403 | chr5:58802617-58802618 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs192113272 | chr5:58802648-58802649 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs550169138 | chr5:58802703-58802704 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs569975904 | chr5:58802752-58802753 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs539105744 | chr5:58802766-58802767 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs66605058 | chr5:58802782-58802783 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs566170703 | chr5:58802838-58802839 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs182273036 | chr5:58802846-58802847 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs374619640 | chr5:58802854-58802855 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs144890942 | chr5:58802861-58802862 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs575540917 | chr5:58802885-58802886 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs574764769 | chr5:58802904-58802905 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs543736920 | chr5:58802964-58802965 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs138567055 | chr5:58802967-58802968 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs575995286 | chr5:58802983-58802984 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs186947563 | chr5:58803014-58803015 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs564780861 | chr5:58803038-58803039 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs554608750 | chr5:58803093-58803094 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs527390736 | chr5:58803104-58803105 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs541192318 | chr5:58803106-58803107 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs372880950 | chr5:58803107-58803108 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs190600248 | chr5:58803112-58803113 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs111262100 | chr5:58803113-58803114 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs536321342 | chr5:58803157-58803158 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs369872650 | chr5:58803158-58803159 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs541070962 | chr5:58803174-58803175 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs550130467 | chr5:58803175-58803176 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs116643245 | chr5:58803227-58803228 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs532358462 | chr5:58803234-58803235 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs35126822 | chr5:58803365-58803366 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs148882960 | chr5:58803375-58803376 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs566007674 | chr5:58803381-58803382 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs56075449 | chr5:58803418-58803419 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs554721822 | chr5:58803494-58803495 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs200741344 | chr5:58803500-58803501 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs557621145 | chr5:58803505-58803506 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs71925624 | chr5:58803506-58803507 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs56226964 | chr5:58803508-58803509 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs61334148 | chr5:58803509-58803510 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs72767798 | chr5:58803510-58803511 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs115883018 | chr5:58803548-58803549 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Autism | 22495311 | CNVD |
Intellectual disability | 22102821 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung cancer | 21911935 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 19602461 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
abnormal development | 18461090 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Lung adenocarcinoma | 17982442 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:58787000-58803800 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr5:58796600-58813200 | Weak transcription | Psoas Muscle | Psoas |
3 | chr5:58799800-58809000 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
4 | chr5:58800600-58815000 | Weak transcription | Rectal Mucosa Donor 31 | rectum |
5 | chr5:58801200-58802600 | Weak transcription | Stomach Mucosa | stomach |
6 | chr5:58801400-58817000 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
7 | chr5:58801800-58804000 | Enhancers | A549 | lung |
8 | chr5:58802600-58803000 | Enhancers | Stomach Mucosa | stomach |
9 | chr5:58802800-58803200 | Enhancers | Primary hematopoietic stem cells | blood |
10 | chr5:58803800-58804800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
11 | chr5:58804000-58804200 | Flanking Active TSS | A549 | lung |
12 | chr5:58804200-58804600 | Enhancers | A549 | lung |
13 | chr5:58804600-58805400 | Flanking Active TSS | A549 | lung |
14 | chr5:58804800-58819800 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
15 | chr5:58805400-58805600 | Enhancers | A549 | lung |
16 | chr5:58805600-58806000 | Weak transcription | A549 | lung |
17 | chr5:58806000-58806400 | Enhancers | A549 | lung |
18 | chr5:58806400-58807000 | Flanking Active TSS | A549 | lung |
19 | chr5:58807000-58807600 | Enhancers | A549 | lung |
20 | chr5:58807600-58807800 | Flanking Active TSS | A549 | lung |
21 | chr5:58807800-58808200 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
22 | chr5:58807800-58812000 | Genic enhancers | A549 | lung |
23 | chr5:58808200-58813200 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
24 | chr5:58809000-58809800 | Enhancers | Pancreatic Islets | Pancreatic Islet |